Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

July 08, 2022 00:22:56
Episode Cover

Restrictive Fluid Resuscitation in Sepsis? The CLASSIC Trial

IVF administration is central to the management of patients with sepsis.  Though the Surviving Sepsis Campaign recently downgraded its recommendation on the amount of...

Listen

Episode

December 05, 2024 00:25:46
Episode Cover

High-Intensity NIPPV for Acute COPD Exacerbations?

NIPPV is frequently used in the management of critically ill patients presenting with an acute COPD exacerbation, as NIPPV decreases the rates of intubation...

Listen

Episode 0

April 13, 2017 00:22:44
Episode Cover

Top 10 Pearls for the Critically Ill Elderly Patient

The number of critically ill elderly patients continues to increase annually.  In this podcast, we discuss key pearls and pitfalls in resuscitating the sick...

Listen